v3.25.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Revenues $ 1,629,662 $ 6,614,029
Cost of goods sold 2,480,072 5,492,825
Gross (loss) profit (850,410) 1,121,204
Operating Expenses    
Research and development 3,432,593 2,669,502
Sales and marketing 3,314,748 1,410,506
General and administrative 4,880,448 3,084,495
Total operating expenses 11,627,789 7,164,503
Operating loss (12,478,199) (6,043,299)
Other (income) expense    
Convertible notes payable fair value adjustment 10,699,677
Interest (income) expense, net (54,525) 12,488
Gain on divestiture of consumer segment (9,642,428)
Impairment on equity method investment 9,058,875
Equity method loss 503,625
Investment income, net (77,254)
Other, net (490,982)
Other expense (income) 10,645,152 (635,676)
Net loss from continuing operations (23,123,351) (5,407,623)
Loss from discontinued operations (1,373,457)
Net loss $ (23,123,351) $ (6,781,080)
Loss per share - basic and diluted    
Continuing operations - basic $ (0.27) $ (0.07)
Continuing operations - diluted (0.27) (0.07)
Discontinued operations - basic (0.02)
Discontinued operations - diluted (0.02)
Loss per share - basic (0.27) (0.09)
Loss per share - diluted $ (0.27) $ (0.09)
Weighted average shares outstanding - basic 85,505,520 74,204,622
Weighted average shares outstanding - diluted 85,505,520 74,204,622

Source